Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marina Moskalenko

Showing results (31-40 of 32) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 32 results.
Journal for Immunotherapy of Cancer|July 15, 2025
Engineered IL-18 variants with half-life extension and improved stability for cancer immunotherapyTravis W Bainbridge, Lifen Wang, Marina Moskalenko, et al.
Science Advances|May 22, 2026
Tumor-targeted bispecific antibodies effectively inhibit oncogenic pathways while minimizing toxicityYvonne T Kschonsak, Wei-Ching Liang, Joyce Chan, et al.
Pageof 4

Showing results (31-40 of 32) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 32 results.
Journal for Immunotherapy of Cancer|July 15, 2025
Engineered IL-18 variants with half-life extension and improved stability for cancer immunotherapyTravis W Bainbridge, Lifen Wang, Marina Moskalenko, et al.
Science Advances|May 22, 2026
Tumor-targeted bispecific antibodies effectively inhibit oncogenic pathways while minimizing toxicityYvonne T Kschonsak, Wei-Ching Liang, Joyce Chan, et al.
Pageof 4